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Postmenopausal symptoms in a
group of rural Xhosa women
Introduction
Menopausal symptoms, though well
tolerated by some women, may be
particularly troublesome in others.
Severe symptoms compromise overall
quality of life for those experiencing
them.1 Hormonal therapy is very
effective in treating these complaints.2
Postmenopausal symptoms are well
known and basically understood by
women in developed countries.
However,  the incidence and
understanding of these symptoms
amongst cultures in developing
countries has long been debated and
remains poorly documented. 3
In a study conducted amongst
urban African women, Mashiloane et
al. found that 40% of women
experienced menopausal symptoms,
but only 19% believed that hot flushes
were related to the menopause.4 While
the incidence of postmenopausal
symptoms amongst rural African
women is not known, it could be
expected that knowledge of the
menopause and possible interventions
would be even less well understood
by such women.
This study was performed to
descr ibe the inc idence and
understanding of early postmeno-
pausal symptoms in rural Xhosa
women from the King Williams Town
district.
Methods
The study was conducted in King
William’s Town in the Eastern Cape
Province of South Africa. The study
population comprised 137 rural Xhosa
women from a culturally homogenous
group. These women, who had a wide
range of complaints, were attending
the private practice of the principal
author. A registered nurse explained
the nature of the study to the women
in their home language. After giving
informed written consent, during which
confidentiality was ensured, the
women were interviewed privately by
the same registered nurse in their
home language. Data was collected
between 18 March and 13 June 2003.
Women >45 years of age with a
period of amenorrhoea of  >12 months
were included. The following exclusion
criteria were applied:
• Unnatural menopause, e.g.
surgical or radiotherapy for cervix
cancer.
• Menopause > five years prior to
study, to avoid loss of recall.
• Medications such as anxiolytics,
antidepressants, anti-hypertensives
and hormonal preparations to avoid
treatment-related effects.
After documenting the descriptive
data, the symptoms were assessed
using a standard instrument, namely
the Greene Climacteric Scale.5 This
widely used tool assesses vasomotor,
somatic and psychological symptoms.
The patient’s body mass index was
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Abstract
Background: To describe the incidence and understanding of early postmenopausal symptoms in rural Xhosa women.
Methods: After written informed consent, 137 women were interviewed within five years after natural menopause using
the Greene Climacteric Scale. Body mass indices were calculated, and blood levels of FSH, LH and oestradiol were
determined.
Results: The mean age of menopause was 50 years amongst the 118 women who met the study criteria. Ninety-four
(80%) patients experienced hot flushes, with 20% describing them as extreme. Sixty-nine percent of patients experienced
nocturnal sweating. Most of the women (111; 94%) had never heard of hormonal therapy. Serum oestradiol levels rose
with increasing body mass index, but did not achieve significance.
Conclusions: These rural South African women experienced the menopause at a comparable age to Caucasian women.
Although they had a high incidence of vasomotor symptoms, they were unaware of the potential benefits of hormonal
therapy.
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then calculated and a blood sample
was drawn to determine the FSH, LH
and oestradiol levels. In addition to
the period of amenorrhoea, patients
who did not have an FSH value of
>30 mIU/ml and a LH value of
>16 mIU/ml were excluded. The
biochemistry results were made
available to the women.
Apar t  f rom numbers  and
percentages, data are expressed as
mean or median with standard
deviation or range. Differences in
means were analysed using the two-
tailed Student’s t-test. A p value of less
than 0.05 was regarded as significant.
The Epi Info 6 software package was
used for the analyses.
Results
All of the 137 women who met the
initial inclusion criteria agreed to
participate. However, upon receipt of
the biochemistry results, 19 women
did not meet the minimum FSH and
LH levels and thus were excluded from
analysis. This left 118 women in the
study group.
The mean age of the group was
53.6 (range 45-61) years, while the
mean age at onset of menopause was
50.2 (range 45-57) years. With regard
to education, 13 (11%) were illiterate
and 35 (30%) had less than eight years
of schooling. Most of the women,
namely 71 (60%), were unemployed.
Of those who were employed, 14
(12%) were skilled, e.g. teachers, and
33 (28%) were unskilled, e.g. cleaners.
The symptoms experienced by the
patients are shown in Table I.
Questions representing symptom
groupings are shown as a footnote
below Table I. Of particular interest
was the fact that 80% of the patients
experienced hot flushes, with 20%
describing them as extreme. Sixty-
nine percent of  the pat ients
experienced sweating at night. Of the
entire group, 111 (94%) had never
heard of hormonal therapy.
The median FSH level was 64.8
mIU/ml (range 30-151), the median
LH level was 33.7 mIU/ml (range 17-
151), and the median oestradiol level
was 86.5 pmol/L (range 65-697). The
median body mass index (BMI) was
29 (range 19-51). Using the BMIs, we
grouped the women into three classes,
namely lean to normal (BMI  25), obese
(BMI 26-35) and morbidly obese (BMI
>35). The serum oestradiol and other
parameters are shown in Table II.
Patients with normal BMIs had
significantly higher FSH and LH levels
and lower (though not significantly so)
oestradiol levels.
Discussion
The mean age of menopause was 50
years. This is up to two years later than
that found by two other African studies,4,6
but earlier than the 51 years of a large
American study amongst Caucasian
women.7 Taken together, these mean
ages probably reflect a normal range
for the onset of natural menopause over
approximately five years.
Our study used strict criteria
(amenorrhoea and gonadotrophins)
to define the natural menopause. This
may be less impor tant when
investigating symptoms widely
accepted as occurring before the
menopause and which include hot
flushes, but is critical when symptoms
of oestrogen withdrawal are reported.
Only 16% of the women in our study
were not troubled by muscle and joint
pain. Although the median BMI in our
group was raised (29), it is not clear
whether this alone can explain these
somatic complaints. Recently, a study
was conducted by telephonic interview
amongst Chinese women aged 40-60
years with a history of natural or
surgical menopause.8 They also found
the most frequently reported symptom
to be muscle and joint pains (57%).
In similar fashion, a Nigerian study6
found joint and bone pains to be the
Symptom
1. Heart beating quickly or strongly
2. Feeling tense or nervous
3. Difficulty in sleeping
4. Excitable
5. Attacks of panic
6. Difficulty in concentrating
7. Feeling tired or lacking in energy
8. Loss of interest in most things
9. Feeling unhappy or depressed
10. Crying spells
11. Irritability
12. Feeling dizzy or faint
13. Pressure or tightness in head or body
14. Parts of body feel numb or tingling
15. Headaches
16. Muscle and joint pains
17. Loss of feeling in hands or feet
18. Breathing difficulties
19. Hot flushes
20. Sweating at night

















































































































Table II: Age and biochemistry within BMI categories
B
BMI 26-35











Note: Questions representing factor groupings: 1-11 psychological factors, 12-18 somatic factors, 19-20
vasomotor symptoms, 21 sexual dysfunction.
Results given as median and range, BMI = body mass index, NS = not significant.
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most prominent symptom (40%).
These similarities therefore extend
across ethnic groups. While certain
authors believe that African Americans
have slower rates of skeletal
remodelling and lower rates of
osteoporosis9 ,  others are not
convinced that there is currently
sufficient research to support this
position.10
As expected, we demonstrated
increasing oestradiol levels with
increasing BMI, but these results did
not achieve significance. However,
morbidly obese women did have
s ign i f icant ly  lower  leve ls  o f
gonadotrophins compared to normal
or lean women. They may therefore
be less prone to vasomotor symptoms
and symptoms of  oest rogen
deficiency, such as vaginal atrophy.
Vasomotor symptoms, consisting
of hot flushes and/or night sweats,
occur in 40-85% of women who
experience a natural menopause.7,11-
13 We intentionally recruited women
with a recent onset of menopause (final
menstruation less than five years prior
to the study) to ensure reliable recall.
The mean duration of menopause in
our study was therefore three years,
compared with 11 years in the one by
Mashiloane et al.4 Of particular interest
was the fact that 80% of the
postmenopausal rural African women
in our study experienced hot flushes,
with 20% describing them as extreme.
This is much higher than the figures
of 48% in the Durban study3 and 30%
in the Nigerian study.6 A study group
from the Netherlands14 also used the
Greene Climacteric Scale to describe
symptoms in their population.
Reporting their results as a mean score
for each item, they found a score of
1.36 for hot flushes in their group of
postmenopausal  women. The
comparative score in this study was
higher, namely 1.48.
While the Durban study4 looked at
u rban Af r ican  women,  ours
investigated the situation amongst
rural African women. Although most
of the women in our study were
unemployed, 59% had a secondary
level of education. Despite this, 94%
of the group had never heard of
hormonal therapy. Mashiloane et al.4
have emphasised the importance of
general practitioners and clinics in
providing relevant health-related
information to communities, including
information relating to hormonal
therapy.
Conclusion
This group of rural South African
women experienced the menopause
at an age comparable to that of
Caucasian women. Although they had
a high incidence of vasomotor
symptoms, they were unaware of the
potential benefits of hormonal therapy.
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